TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11124353

Group type: EXPERIMENTAL
Intervention: Analog number representations in young children
Number of subjects: 0
Study: 9205921

Group type: EXPERIMENTAL
Intervention: Snakebrush
Number of subjects: 60

Group type: COMPARATOR
Intervention: Flexible brush
Number of subjects: 60

Group type: COMPARATOR
Intervention: Precision brush
Number of subjects: 60
Study: 8201080

Group type: EXPERIMENTAL
Intervention: On-task and coping thoughts in children with high test anxiety
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Positive self-evaluations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Positive cognition
Number of subjects: 0
Study: 2452564

Group type: EXPERIMENTAL
Intervention: Prourokinase (7.5 mg bolus + 40.5 mg infusion over 60 minutes)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Prourokinase (7.5 mg bolus + 66.5 mg infusion over 60 minutes)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Combination of prourokinase (3.7 mg bolus + 250,000 IU urokinase + 44.3 mg prourokinase)
Number of subjects: 54
Study: 31617568

Group type: EXPERIMENTAL
Intervention: 2-dose (2D) quadrivalent HPV vaccine
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: 3-dose (3D) quadrivalent HPV vaccine
Number of subjects: 103

Group type: COMPARATOR
Intervention: 3-dose (3D) quadrivalent HPV vaccine in women aged 16-26
Number of subjects: 103
Study: 28918395

Group type: EXPERIMENTAL
Intervention: nHFOV
Number of subjects: 26

Group type: COMPARATOR
Intervention: nCPAP
Number of subjects: 26
Study: 27107326

Group type: EXPERIMENTAL
Intervention: Eribulin
Number of subjects: 154
Study: 26424362

Group type: EXPERIMENTAL
Intervention: Guided Imagery and Music (GIM)
Number of subjects: 20

Group type: COMPARATOR
Intervention: wait-list control
Number of subjects: 20
Study: 24227740

Group type: EXPERIMENTAL
Intervention: Patient with focal lesion of the right postcentral gyrus
Number of subjects: 1

Group type: COMPARATOR
Intervention: Age-matched controls
Number of subjects: 1

Group type: COMPARATOR
Intervention: Right-hemisphere stroke patients (group analysis)
Number of subjects: 1
Study: 21400636

Group type: EXPERIMENTAL
Intervention: Media literacy programme (n=143)
Number of subjects: 443

Group type: EXPERIMENTAL
Intervention: Media literacy plus nutrition awareness programme (n=99)
Number of subjects: 443

Group type: COMPARATOR
Intervention: Control group (n=201)
Number of subjects: 443
Study: 18188711

Group type: EXPERIMENTAL
Intervention: rhEPOalpha treatment (n = 50)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group (n = 58)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: EPO receptor protein expression
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Ki-67 index
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Systemic inflammation (ESR)
Number of subjects: 108
Study: 16949494

Group type: EXPERIMENTAL
Intervention: Acute serial cardioversion
Number of subjects: 144

Group type: COMPARATOR
Intervention: Routine serial cardioversion
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 144

Group type: COMPARATOR
Intervention: Digoxin
Number of subjects: 144
Study: 12612902

Group type: EXPERIMENTAL
Intervention: Medical therapy plus TIPS
Number of subjects: 109

Group type: COMPARATOR
Intervention: Medical therapy alone
Number of subjects: 109
Study: 10565650

Group type: EXPERIMENTAL
Intervention: Fibrin tissue adhesive
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group (standard means of hemostasis)
Number of subjects: 58
Study: 8740106

Group type: COMPARATOR
Intervention: Miconazole oral gel (Daktar, Janssen)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Nystatin oral gel (Candio‐Hermal)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Nystatin oral gel (Lederlind)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Overall mycologic cure rate
Number of subjects: 95
Study: 1831972

Group type: EXPERIMENTAL
Intervention: Cognitive treatment (with or without relaxation training)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Behavioural treatment (with or without relaxation training)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Combined psychological/physiotherapy treatment conditions
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Behavioural conditions
Number of subjects: 58

Group type: COMPARATOR
Intervention: Attention (physiotherapy plus discussion sessions)
Number of subjects: 58

Group type: COMPARATOR
Intervention: No-attention (physiotherapy-only)
Number of subjects: 58
Study: 6129364

Group type: EXPERIMENTAL
Intervention: Diet low in fat (23% of energy) with a high polyunsaturated/saturated (P/S) ratio (1.0)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Reduced daily salt intake from 192 mmol to 77 mmol
Number of subjects: 57

Group type: COMPARATOR
Intervention: Usual diet (control group)
Number of subjects: 57
Study: 30531779

Group type: EXPERIMENTAL
Intervention: Endovascular revascularization (ER) with SFA stenting
Number of subjects: 234

Group type: COMPARATOR
Intervention: Loop endarterectomy (LE)
Number of subjects: 234
Study: 27063247

Group type: EXPERIMENTAL
Intervention: Caffeine (5mg·kg(‐1))
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 24985938

Group type: EXPERIMENTAL
Intervention: Regular preoperative beta blockers
Number of subjects: 69

Group type: COMPARATOR
Intervention: No preoperative beta blockers (Control)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Ipsilateral moderate carotid stenosis (60-80%)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Intraoperative hemodynamic values
Number of subjects: 69
Study: 22261362

Group type: EXPERIMENTAL
Intervention: Conventional chemoradiotherapy (70 Gy in 7 weeks plus three cycles of 4 days' concomitant carboplatin‐fluorouracil)
Number of subjects: 840

Group type: EXPERIMENTAL
Intervention: Accelerated radiotherapy‐chemotherapy (70 Gy in 6 weeks plus two cycles of 5 days' concomitant carboplatin‐fluorouracil)
Number of subjects: 840

Group type: EXPERIMENTAL
Intervention: Very accelerated radiotherapy (64·8 Gy [1·8 Gy twice daily] in 3·5 weeks)
Number of subjects: 840
Study: 19946861

Group type: EXPERIMENTAL
Intervention: ADAS-cog
Number of subjects: 1566

Group type: EXPERIMENTAL
Intervention: CAMCOG
Number of subjects: 1566

Group type: EXPERIMENTAL
Intervention: MMSE
Number of subjects: 1566
Study: 18940117

Group type: EXPERIMENTAL
Intervention: Aloe vera gel
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 16180951

Group type: EXPERIMENTAL
Intervention: Problem-oriented willed-movement (POWM) therapy
Number of subjects: 47

Group type: COMPARATOR
Intervention: Neurodevelopmental treatment (NDT)
Number of subjects: 47
Study: 12844392

Group type: EXPERIMENTAL
Intervention: Linoleic acid added to ice creams
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (ice creams without linoleic acid)
Number of subjects: 24
Study: 11305734

Group type: EXPERIMENTAL
Intervention: U‐73122 (phospholipase C inhibitor)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control (healthy volunteers)
Number of subjects: 15
Study: 8831164

Group type: EXPERIMENTAL
Intervention: Negative individual performance feedback
Number of subjects: 0

Group type: COMPARATOR
Intervention: No negative individual performance feedback
Number of subjects: 0
Study: 1564708

Group type: EXPERIMENTAL
Intervention: First menstrual cycle after IVF
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Second menstrual cycle after IVF
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Third menstrual cycle after IVF
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Overall ovulatory cycles
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Ovulatory cycles with luteal phase deficiencies
Number of subjects: 35
Study: 4075795

Group type: EXPERIMENTAL
Intervention: 250 micrograms Sulprostone
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: 500 micrograms Sulprostone
Number of subjects: 200
Study: 29723443

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 29132804

Group type: EXPERIMENTAL
Intervention: Lighted Stylet
Number of subjects: 62

Group type: COMPARATOR
Intervention: GlideScope
Number of subjects: 62
Study: 26652037

Group type: EXPERIMENTAL
Intervention: β-alanine supplementation
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 25131977

Group type: EXPERIMENTAL
Intervention: Automatic, daily, implant-based, multiparameter telemonitoring in addition to standard care
Number of subjects: 716

Group type: COMPARATOR
Intervention: Standard care without telemonitoring
Number of subjects: 716

Group type: EXPERIMENTAL
Intervention: Telemonitoring group
Number of subjects: 716

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 716
Study: 22241570

Group type: EXPERIMENTAL
Intervention: Gravity-assisted drainage position (20° head-down tilt)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Modified drainage position (no head-down tilt)
Number of subjects: 20
Study: 19841925

Group type: EXPERIMENTAL
Intervention: 0.2% ropivacaine (catheter group)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Normal saline solution (single-shot group)
Number of subjects: 70
Study: 18490003

Group type: EXPERIMENTAL
Intervention: Vascular depression features
Number of subjects: 0
Study: 16146546

Group type: EXPERIMENTAL
Intervention: Tacrolimus
Number of subjects: 186

Group type: COMPARATOR
Intervention: Cyclosporine
Number of subjects: 186
Study: 14519754

Group type: EXPERIMENTAL
Intervention: Selenium supplementation (200 microg daily)
Number of subjects: 1312
Study: 10820295

Group type: EXPERIMENTAL
Intervention: Chiropractic diagnostic methods (visual postural analysis, pain description, plain static erect x-ray, leg length discrepancy, neurologic tests, motion palpation, static palpation, orthopedic tests)
Number of subjects: 38
Study: 8873109

Group type: EXPERIMENTAL
Intervention: High-dose UL ECT (three times the threshold)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-dose UL ECT (threshold)
Number of subjects: 0
Study: 1505422

Group type: EXPERIMENTAL
Intervention: Daily brushing (96% reported brushing daily)
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Clinical examination using WHO criteria
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Dental visits (39% had visited a dentist before, 16% at least once a year)
Number of subjects: 243
Study: 3965236

Group type: EXPERIMENTAL
Intervention: Oral pentoxifylline (400 mg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Intravenous pentoxifylline (200 mg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Oral and intravenous dosing
Number of subjects: 10
Study: 31650861

Group type: EXPERIMENTAL
Intervention: Nutritional supplement adherence
Number of subjects: 158
Study: 31409380

Group type: EXPERIMENTAL
Intervention: CNS-focused treatment program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard medical and physical therapy care
Number of subjects: 0
Study: 30404504

Group type: EXPERIMENTAL
Intervention: 20kHz ultrasound stimulus presented continuously for 20 minutes at 84dB SPL, 15dB below detection threshold
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham presentation (control group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Expectation of ultrasound presence (nocebo response)
Number of subjects: 0
Study: 27853357

Group type: EXPERIMENTAL
Intervention: mHealth management system with adherence sensor and mobile app (4 participants)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: mHealth management system with adherence sensor (3 participants)
Number of subjects: 7
Study: 23982929

Group type: EXPERIMENTAL
Intervention: AG/GG genotype of rs5995355 in NCF4
Number of subjects: 2019
Study: 22751874

Group type: EXPERIMENTAL
Intervention: Cholecalciferol (vitamin D3) 2000 IU daily
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 20685683

Group type: EXPERIMENTAL
Intervention: Combination of forced-air and a circulating-water mattress (CWM)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Circulating-water garment (CWG)
Number of subjects: 50
Study: 17389290

Group type: EXPERIMENTAL
Intervention: Computerized alerts with pharmacist-mediated academic detailing
Number of subjects: 853
Study: 18378968

Group type: EXPERIMENTAL
Intervention: Bonfils intubation fibrescope (BIF)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Direct laryngoscopy (Macintosh blade)
Number of subjects: 76
Study: 15611465

Group type: EXPERIMENTAL
Intervention: Total extraperitoneal inguinal hernioplasty with mesh fixation using staples
Number of subjects: 170

Group type: COMPARATOR
Intervention: Total extraperitoneal inguinal hernioplasty without mesh fixation
Number of subjects: 170
Study: 15887713

Group type: EXPERIMENTAL
Intervention: ICCE with anterior chamber intraocular lens (AC IOL)
Number of subjects: 502

Group type: COMPARATOR
Intervention: ICCE with aphakic spectacles (AS)
Number of subjects: 502

Group type: COMPARATOR
Intervention: Comparison between ICCE/AC IOL and ICCE/AS
Number of subjects: 502

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 502
Study: 8985273

Group type: EXPERIMENTAL
Intervention: Ketoconazole
Number of subjects: 211

Group type: COMPARATOR
Intervention: Griseofulvin
Number of subjects: 211
Study: 8107548

Group type: EXPERIMENTAL
Intervention: Run-only training (N = 6)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Cycle/run training (N = 5)
Number of subjects: 11
Study: 3313101

Group type: EXPERIMENTAL
Intervention: Azathioprine with steroids
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Azathioprine without steroids
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31274608

Group type: EXPERIMENTAL
Intervention: Parotid gland massage
Number of subjects: 100

Group type: COMPARATOR
Intervention: Nonmassage group
Number of subjects: 100
Study: 28831535

Group type: EXPERIMENTAL
Intervention: Screening group (individuals at moderate-to-high risk invited for assessment)
Number of subjects: 1912392

Group type: COMPARATOR
Intervention: No-screening group (retrospectively constructed control group)
Number of subjects: 1912392
Study: 26248828

Group type: COMPARATOR
Intervention: Continuing antibiotics group (CAG)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Discontinuing antibiotics group (DAG)
Number of subjects: 0
Study: 23799356

Group type: EXPERIMENTAL
Intervention: Hormone Therapy (HT)
Number of subjects: 16347

Group type: EXPERIMENTAL
Intervention: Calcium and Vitamin D (CaD)
Number of subjects: 16347

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16347
Study: 22728026

Group type: EXPERIMENTAL
Intervention: nab-paclitaxel 150 mg/m(2) qw 3/4
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: nab-paclitaxel 100 mg/m(2) qw 3/4
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: nab-paclitaxel 300 mg/m(2) q3w
Number of subjects: 302

Group type: COMPARATOR
Intervention: docetaxel 100 mg/m(2) q3w
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: all nab-paclitaxel arms
Number of subjects: 302
Study: 19553282

Group type: COMPARATOR
Intervention: Best Practice (BP) only
Number of subjects: 360

Group type: COMPARATOR
Intervention: Best Practice plus ultrasound feedback (BP+US)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Motivational Interviewing‐based counseling plus ultrasound feedback (MI+US)
Number of subjects: 360
Study: 17684468

Group type: EXPERIMENTAL
Intervention: Chromium picolinate and biotin combination (600 microg chromium as chromium picolinate and 2 mg biotin)
Number of subjects: 348

Group type: EXPERIMENTAL
Intervention: Chromium picolinate and biotin combination
Number of subjects: 348

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 348
Study: 15963313

Group type: EXPERIMENTAL
Intervention: People with Arthritis Can Exercise program
Number of subjects: 347

Group type: COMPARATOR
Intervention: Noncompleters of the program
Number of subjects: 347
Study: 11967494

Group type: EXPERIMENTAL
Intervention: Topical application of 0.01% recombinant human platelet-derived growth factor gel
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 21
Study: 9577944

Group type: EXPERIMENTAL
Intervention: Intracoronary (IC) enalaprilat (0.05 mg/min for 15 minutes)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Sublingual (SL) captopril (25 mg)
Number of subjects: 20
Study: 8588830

Group type: EXPERIMENTAL
Intervention: Syncroner (2 puffs of 2 mg 4 times a day for two weeks)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Standard mouthpiece (2 puffs of 2 mg 4 times a day for two weeks)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Syncroner
Number of subjects: 144
Study: 2501133

Group type: EXPERIMENTAL
Intervention: 15 micrograms enprostil
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 25 micrograms enprostil
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 35 micrograms enprostil
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 46712

Group type: EXPERIMENTAL
Intervention: Progesterone-releasing devices (various doses)
Number of subjects: 402

Group type: COMPARATOR
Intervention: Placebo (empty device)
Number of subjects: 402
Study: 31038562

Group type: EXPERIMENTAL
Intervention: sitagliptin 100 mg per day + metformin + insulin glargine
Number of subjects: 70

Group type: COMPARATOR
Intervention: voglibose 0.2 mg three times daily + metformin + insulin glargine
Number of subjects: 70
Study: 28318744

Group type: EXPERIMENTAL
Intervention: CPRA >80%
Number of subjects: 3855

Group type: COMPARATOR
Intervention: CPRA ≤10%
Number of subjects: 3855
Study: 25545757

Group type: EXPERIMENTAL
Intervention: Oral glutamic acid
Number of subjects: 250

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 250
Study: 23915518

Group type: EXPERIMENTAL
Intervention: Olmesartan
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 30
Study: 21277566

Group type: EXPERIMENTAL
Intervention: Hydrocortisone (20 mg)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Hydrocortisone (60 mg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 19901314

Group type: EXPERIMENTAL
Intervention: Primary outcome
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Secondary outcome
Number of subjects: 110
Study: 16703733

Group type: EXPERIMENTAL
Intervention: Tadalafil 20 mg
Number of subjects: 64

Group type: COMPARATOR
Intervention: Sildenafil 50 mg
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Tadalafil dosing instructions
Number of subjects: 64

Group type: COMPARATOR
Intervention: Sildenafil dosing instructions
Number of subjects: 64
Study: 15149872

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT) and Vitamin C and E (VCE)
Number of subjects: 80
Study: 11562616

Group type: EXPERIMENTAL
Intervention: Semi-demand feeding protocol
Number of subjects: 81

Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 81
Study: 9197298

Group type: COMPARATOR
Intervention: Thiopental/nitrous oxide
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Halothane
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 66
Study: 8181124

Group type: EXPERIMENTAL
Intervention: Percutaneous transluminal coronary angioplasty (PTCA)
Number of subjects: 227

Group type: COMPARATOR
Intervention: Drug therapy
Number of subjects: 227
Study: 2884114

Group type: EXPERIMENTAL
Intervention: Fenoldopam mesylate 100 mg under fed conditions
Number of subjects: 8

Group type: COMPARATOR
Intervention: Fenoldopam mesylate 100 mg under fasting conditions
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: SK&F 87782 under fed conditions
Number of subjects: 8

Group type: COMPARATOR
Intervention: SK&F 87782 under fasting conditions
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Fenoldopam 24-hour excretion under fed conditions
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: SK&F 87782 24-hour excretion under fed conditions
Number of subjects: 8
Study: 31284794

Group type: EXPERIMENTAL
Intervention: PF-06438179/GP1111 (PF-SZ-IFX)
Number of subjects: 650

Group type: COMPARATOR
Intervention: Reference infliximab (ref-IFX-EU)
Number of subjects: 650
Study: 28874948

Group type: EXPERIMENTAL
Intervention: Electronic prescriptions (E-prescriptions)
Number of subjects: 2883

Group type: COMPARATOR
Intervention: Handwritten prescriptions (HW)
Number of subjects: 2883
Study: 26892359

Group type: EXPERIMENTAL
Intervention: Oral midazolam 1 mg/kg (MS)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo (PS)
Number of subjects: 18
Study: 24261665

Group type: EXPERIMENTAL
Intervention: GNUMAP-bs alignment algorithm
Number of subjects: 0

Group type: COMPARATOR
Intervention: Other commonly-used bisulfite alignment methods
Number of subjects: 0
Study: 22123804

Group type: EXPERIMENTAL
Intervention: Intravenous methylprednisolone (0.5 mg/kg every 6 hours for 72 hours, 0.5 mg/kg every 12 hours on days 4 through 6, and 0.5 mg/kg/d on days 7 through 10)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Intravenous methylprednisolone
Number of subjects: 83
Study: 19389421

Group type: EXPERIMENTAL
Intervention: Intervention group (n=16)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Active comparison group (n=17)
Number of subjects: 33
Study: 16368364

Group type: EXPERIMENTAL
Intervention: Complementary therapy (preoperative guided imagery training with gentle touch or light massage and postoperative music with gentle touch or light massage and guided imagery)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 104
Study: 15516551

Group type: EXPERIMENTAL
Intervention: Minimal-contact psychotherapy
Number of subjects: 216

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 216
Study: 10676792

Group type: EXPERIMENTAL
Intervention: Optical pachymetry
Number of subjects: 1717

Group type: EXPERIMENTAL
Intervention: Slitlamp‐mounted ultrasound
Number of subjects: 1717

Group type: EXPERIMENTAL
Intervention: Handheld ultrasound
Number of subjects: 1717
Study: 9770938

Group type: EXPERIMENTAL
Intervention: Collagen-alginate wound dressing
Number of subjects: 20

Group type: COMPARATOR
Intervention: Soaks and daily dressing changes
Number of subjects: 20
Study: 2901120

Group type: EXPERIMENTAL
Intervention: Alpidem 50 mg
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Alpidem 75 mg
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Alpidem 50-150 mg/day for 3-4 weeks
Number of subjects: 188

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 188
Study: 30852837

Group type: EXPERIMENTAL
Intervention: Oxycodone (0.03 mg/kg)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91